HOME › DRUGS › IMIPENEM;CILASTATIN;RELEBACTAM
ACTIVE SUBSTANCE / INN

IMIPENEM;CILASTATIN;RELEBACTAM

Brand name(s): Recarbrio
EMA LISTED
AUTHORISED
Gram-Negative Bacterial Infections
ACTIVE SUBSTANCE
Imipenem;Cilastatin;Relebactam
REGULATORS
EMA
SPONSORS / MAH
Merck Sharp & Dohme B.V. 
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
RecarbrioMerck Sharp & Dohme B.V. Authorised13/02/2020Gram-Negative Bacterial Infections

FULL INTELLIGENCE ON IMIPENEM;CILASTATIN;RELEBACTAM

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →